BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 3115639)

  • 1. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
    Stingl LA; Sinska A; Landesmann U; Smolen JS
    Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
    J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    Schwab R; Crow MK; Russo C; Weksler ME
    J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors.
    Smith KG; Austyn JM; Hariri G; Beverley PC; Morris PJ
    Eur J Immunol; 1986 May; 16(5):478-86. PubMed ID: 2938973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Palacios R
    Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
    Ceuppens JL; Baroja ML
    J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
    Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
    Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell activation by cross-linking anti-CD3 antibodies with second anti-T cell antibodies: dual antibody cross-linking mimics physical monocyte interaction.
    Walker C; Bettens F; Pichler WJ
    Eur J Immunol; 1987 Nov; 17(11):1611-8. PubMed ID: 2960544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL; Bloemmen FJ; Van Wauwe JP
    J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
    van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA
    Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3.
    van Lier RA; Boot JH; Verhoeven AJ; de Groot ER; Brouwer M; Aarden LA
    J Immunol; 1987 Nov; 139(9):2873-9. PubMed ID: 3117878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3.
    Geppert TD; Lipsky PE
    J Immunol; 1987 Mar; 138(6):1660-6. PubMed ID: 3102594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
    Walker C; Bettens F; Pichler WJ
    Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal delivery by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T-cell proliferation. Synergistic effect of BSF-2/IL-6 and IL-1.
    Kawakami K; Kakimoto K; Shinbori T; Onoue K
    Immunology; 1989 Jul; 67(3):314-20. PubMed ID: 2503436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.
    Tax WJ; Hermes FF; Willems RW; Capel PJ; Koene RA
    J Immunol; 1984 Sep; 133(3):1185-9. PubMed ID: 6235283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
    Van Lier RA; Boot JH; De Groot ER; Aarden LA
    Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside.
    Welte K; Miller G; Chapman PB; Yuasa H; Natoli E; Kunicka JE; Cordon-Cardo C; Buhrer C; Old LJ; Houghton AN
    J Immunol; 1987 Sep; 139(6):1763-71. PubMed ID: 2887619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.